Failure of lymphocyte microcytotoxicity to distinguish relapsers from non-relapsers in melanoma patients receiving post-surgical adjuvant chemotherapy
- PMID: 658104
- DOI: 10.1016/0014-2964(78)90011-7
Failure of lymphocyte microcytotoxicity to distinguish relapsers from non-relapsers in melanoma patients receiving post-surgical adjuvant chemotherapy
Similar articles
-
Lymphocyte mediated reactivity against malignant melanoma detected by a microcytotoxicity assay employing technetium-99m labeled target cells.Cancer. 1978 Jun;41(6):2174-82. doi: 10.1002/1097-0142(197806)41:6<2174::aid-cncr2820410616>3.0.co;2-m. Cancer. 1978. PMID: 350374 Review. No abstract available.
-
Evaluation of cell-mediated reactivity and serum blocking factors in melanoma patients on chemotherapy.Med Pediatr Oncol. 1975;1(3):195-206. doi: 10.1002/mpo.2950010303. Med Pediatr Oncol. 1975. PMID: 1232528
-
Lymphocyte function and response to chemo-immunotherapy in patients with metastatic melanoma.Br J Cancer. 1977 Dec;36(6):751-62. doi: 10.1038/bjc.1977.258. Br J Cancer. 1977. PMID: 597473 Free PMC article.
-
Chemoimmunotherapy increases the lymphocyte reactivity of melanoma patients.Eur J Cancer (1965). 1979 Feb;15(2):197-204. doi: 10.1016/0014-2964(79)90060-4. Eur J Cancer (1965). 1979. PMID: 436896 Clinical Trial. No abstract available.
-
Therapy for cutaneous melanoma: an update.J Am Acad Dermatol. 1990 Feb;22(2 Pt 1):159-76. doi: 10.1016/0190-9622(90)70019-e. J Am Acad Dermatol. 1990. PMID: 2179292 Review.
Cited by
-
Serial immune function testing to predict clinical disease relapse in patients with solid tumors.Cancer Immunol Immunother. 1983;15(3):165-71. doi: 10.1007/BF00199159. Cancer Immunol Immunother. 1983. PMID: 6352007 Free PMC article. Review. No abstract available.
-
Serial immune testing in surgically resected lung cancer patients.Cancer Immunol Immunother. 1983;15(2):114-20. doi: 10.1007/BF00199701. Cancer Immunol Immunother. 1983. PMID: 6603261 Free PMC article.